Schedule - CEESTAHC Poland

Home

Forum

Contact

Main / EBHC Symposium / Schedule

EBHC Symposium

The form of Symposium assumes longer time for discussion with eminent experts, which will allow the participants to benefit from their knowledge to a greater degree than is usual for this kind of meetings. Communication will be facilitated by simultaneous translation of all presentations into English and Polish. On behalf of all the persons and institutions engaged in organization of the Symposium we heartily invite you to take part in this event, so important for economic and medical environment.

Day 1 - Monday, October 10^th, 2011
Topics	Speakers	Timing
Opening of the Symposium: Magdalena Władysiuk, David Banta		9:30 9:40
Session 1: Have EBM and HTA changed the face of medicine?		9:40 11:15
Health Technology Assessment-Past, Present and Future	Duncan Nauhaser	40 min.
Has HTA changed the face of medicine?	David Banta	40 min.
Coffee break		20 min.
Session 2: Polish presidency of the EU Council – discussion on cooperation and the role of EBHC solutions in realisation of priorities in health care		11:35 12:50
Public health as a modern way to solve health problems	Bolesław Samoliński	10 min.
Do we need a new paradigm in evaluation of the society health? – the Fit for Work report	Magdalena Władysiuk	10 min.
Priorytety i działania Ministerstwa Zdrowia w ramach polskiej prezydencji w Radzie Unii Europejskiej	Adam Fronczak	10 min.
Disscussion panel: Dante Cornago, Andrea Rappagliosi, David Banta, Alric Ruther		30 min.
Coffee break		20 min.
Session 3: Polish way to HTA		13:10 14:40
Polish way to HTA	Wojciech Matusewicz	25 min.
New challenges for AHTAPol in view of the reimbursement act	Krzysztof Mączka	25 min.
Function of the Transparency Council in new circumstances	Łukasz Andrzejczyk	25 min.
Lunch		40 min.
Session 4: Comparative effectivenes or relative effectivenes?		15:20 16:50
Comparative Effectiveness Research and HTA in the United States: Promoting Evidence-based Decision Making	Jean Slutsky	25 min.
Do medications keep their words after marketing approval?	Eric Van Ganse	25 min.
Cost studies in Polish circumstances – the Economedica experience	Magdalena Władysiuk	25 min.

Day 2 - Tuesday, October11^th, 2011
Topics	Speakers	Timing
Session 5: International cooperation in view of new challenges		10:00 11:30
HTAi – developing and promoting best practice for patient-focused HTAs	Karen Facey	25 min.
Health Technology Assessment International: a global collaboration	Laura Sampietro-Colom	25 min.
The European Network for Health Technology Assessment (EUnetHTA): developments, achievements and challenges	Alric Ruther	25 min.
Coffee break		20 min.
Parallel Session I – room C Prescribing - new approaches		11:50 12:50
Can multiple demand side measures enhance prescribing efficiency; implications for sustaining healthcare systems? Godman B, Wettermark B, Burkhardt T, Malinowska K, Sermet C, Zara C		15 min.
Differences in the influence of prescribing restrictions; implications for health policy interventions and resource savi Godman B, Sakshaug S, Berg C, Burkhard T, Luka Vončina L, Vlahović-Palčevski V, Wettermark B		15 min.
Enhancing the utilisation of generic clopidogrel: potential guidance from Eastern and Western European countries Baumgaertel C, Godman B, Skiöld P, Bishop I, Burkhardt T, Furst J, Garuoliene K, Koskinen H, Malinowska K, Ringerud AM, Sermet C, Teixeira I, Vončina L, Zara C		15 min.
Modelowanie w HTA – problemy metodyczne / Economic models in HTA – methodological problems Żerda I, Plisko R, Gwiosda B		15 min.
Parallel Session II - room D Recent changes in selected countries		11:50 13:05
Is there place for HTA in Russia? Borisenko O		15 min.
Review of health technology assessment (HTA) development in Serbia Stefanovic M, Atanasijevic D		15 min.
Evidence of evidence based healthcare development in Romania Scintee SG, Vladescu C		15 min.
Metaanaliza sieciowa – zalety i wady Wójcik R		15 min.
Czy porównanie pośrednie jest zawsze możliwe? / Is indirect comparison always possible? Jaros P, Skarżyńska-Duk J, Ryś P, Władysiuk M		15 min.
Parallel Session III – room E Pricing in practice		11:50 13:05
High rate of self purchasing of oral antibiotics in Serbia: implications for future policies Bajcetic M, Kalaba M, Sipetic T, Godman B, Coenen S, Goossens H		15 min.
European countries with small populations can obtain appreciable price reductions; example of Lithuania Garuoliene K, Gulbinovič J, Godman B, Wettermark B, Haycox A		15 min.
Perspectives of risk sharing agreements and the brazilian health care system Curi R, Godman B, Adamski J		15 min.
Based on data from the plato study ticagrelor reduces non-drug health-care costs compared with clopidogrel in patients with acute coronary syndrome (ACS) from a polish healthcare perspective Nikolic E, Henriksson M, Mellström C, Macioch T, Niewada M, Perkowski P, Faluta T, Budaj A, Wallentin L		15 min.
Pricing policy and reimbursement in Norway – implementing HTA in decision making Hviding K		15 min.
Coffee break		25 min.
Session 6: "Heavy" and "light" HTA agencies – agency models worldwide		13:30 15:40
Reimbursement decision-making and health technology assessment – Recent developments in Hungary	David Danko	25 min.
Guidelines for Pharmacoeconomic evaluation for Serbia	Tanja Novakovic	25 min.
The role of HTA in promoting efficiency in the French healthcare system	Isabelle Durand-Zaleski	40 min.
Scottish Medicines Consortium – 10 Years HTA of New Medicines	Ken Paterson	25 min.
Lunch		40 min.
Session 7: Changes in the function of HTA in reimbursement and pricing systems		16:20 17:20
Industry as a stakeholder in HTA	Mitch Sugarman	20 min.
Recent developments in the pricing, reimbursement and funding of drugs in Europe: implications for all key stakeholder groups	Brian Godman	20 min.
Closure of the Symposium	Magdalena Władysiuk	5 min.

ebm, hta, ebhc, fe, health technology assessment, evidence-based health care, evidence based health care, szkolenie, szkolenia, kurs, kursy, metaanaliza, metaanalizy, rct, koszyk świadczeń, benefit package, poland, kraków, mutual review, recenzje wzajemne, peer review, PRS, CEESTAHC, EBM, HTA, Polska, medycyna oparta na dowodach naukowych, htai, eunethta, hen, who, program szkoleń, CI, RR, RRR, OR, ARR, NNT, NNH, ocena wiarygodności badań, analiza wiarygodności badań, wiarygodność badań, test diagnostyczny, testy diagnostyczne, przegląd systematyczny, przeglądy systematyczne, medyczne bazy danych, bazy informacji medycznej, strategie wyszukiwania, strategia wyszukiwania, statystyka medyczna, istotność statystyczna, istotność kliniczna, homogeniczność badań, heterogeniczność badań, wytyczne oceny technologii medycznych, aotm, analiza efektywności, efektywność, analiza wrażliwości, refundacja, dyskontowanie kosztów, analiza wpływu na budżet, budget impact, raport hta, raporty hta, analiza hta, analizy hta, metody ustalania cen, pricnig, farmakoekonomika, medline, cochrane library, biblioteki medyczne, łanda, plisko, władysiuk, blicharz, władysiuk-blicharz, ryś, siwiec, konferencja, konferencje, sympozjum ebhc, sympozja, oferta, oferty

• PIPERSKA Workshop
March 19-21, 2012, Slovenia

Program (190 kB)

Info (1,3 MB)